Work

ID: 335853 Initial Clinical Safety and Feasibility from RESET-RA Study: Novel Neuroimmune Modulation Device for Rheumatoid Arthritis

Year: 2024

Type: article

Source: Neuromodulation Technology at the Neural Interface

DOI: 10.1016/j.neurom.2024.06.340

Authors: David Chernoff, Daniel Peterson, Mark Van Poppel, Warren Boling, Perry Santos, Jason Schwalb, Howard Eisenberg, Ashesh Mehta, Heather Spader, James Botros, Frank Vrionis, Andrew Ko, P. David Adelson, Bradley Lega, Peter Konrad, Mark Richardson

Institutions: California Institute of the Arts, Carolina Neurosurgery and Spine Associates, Loma Linda University, Loma Linda University Health Care, INTEGRIS Baptist Medical Center, University of Maryland Medical Center, Feinstein Institute for Medical Research, University of New Mexico, University of Washington, Rockefeller University, The University of Texas Southwestern Medical Center, West Virginia University, West Virginia University Hospitals, Massachusetts General Hospital

Language: English

Topic: Vagus Nerve Stimulation Research

Subfield: Neurology

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403105642

FWCI:

Cites:

Cited by:

Related to: 10